Activation of nuclear factor-kappaB (NF-κB) signaling has been identified as an important molecular link between inflammation and cancer, and modulates tumor growth, chemotherapy resistance, and immune escape in a variety of malignancies, including ovarian cancer [15–17]. This evidence concerns the gene NFKB1 and ovarian cancer.